Skip to content

Comparison of analgesic effects of different postoperative analgesic regimens for gastrointestinal surgery and their effects on postoperative recovery

Comparison of analgesic effects of different postoperative analgesic regimens for gastrointestinal surgery and their effects on postoperative recovery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080651
Enrollment
Unknown
Registered
2024-02-04
Start date
2024-02-05
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia and postoperative recovery

Interventions

oxycodone group:NA
sufentani group:NA

Sponsors

Jiangsu Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing gastrointestinal surgery in Jiangsu Cancer Hospital from 2022.01 to 2023.12; 2.Patients with ASA class II-III; 3.BMI 18-30kg/m^2; 4.Postoperative patient-controlled intravenous analgesia was performed.

Exclusion criteria

Exclusion criteria: 1.Chronic pain with long-term use of analgesics or psychotropic drugs; 2.The heart, lung, liver and kidney functions were severely abnormal; 3.Patients with severe allergies and a history of asthma; 4.Mentally ill person; 5.Diseases related to the immune system or other treatments that may affect immune function.

Design outcomes

Primary

MeasureTime frame
Numerical rating scale for pain;

Secondary

MeasureTime frame
Lymphocyte subpopulation;Liver function;Renal function;The first passage of flatus ;The first bowel movement;the Barthelindex of ADL;Postoperative hospital stay;Removal time of nasogastric tube ;Removal time of nasojejunal tube;

Countries

China

Contacts

Public ContactLiu Hui

Jiangsu Cancer Hospital

huilium163@163.com+86 138 1304 3213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026